Freestone Capital Holdings’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,279
Closed -$210K 409
2023
Q1
$210K Buy
+3,279
New +$214K 0.01% 329
2022
Q4
Sell
-3,291
Closed -$232K 397
2022
Q3
$232K Buy
3,291
+12
+0.4% +$1.03K 0.01% 325
2022
Q2
$233K Buy
+3,279
New +$211K 0.01% 368

Other funds holding STAA

Freestone Capital Holdings's STAA Position: Q2 2023 in Review

Freestone Capital Holdings sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 3,279 shares — an estimated $210K sold.

Freestone Capital Holdings first reported a position in STAA in Q2 2022 and held it in 3 quarters. The position peaked at $233K in Q2 2022. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Freestone Capital Holdings reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Freestone Capital Holdings sold 3,279 STAAR Surgical shares in Q2 2023, an estimated $210K.
  • Freestone Capital Holdings first reported a position in STAAR Surgical in Q2 2022 and held it in 3 quarters.
  • Freestone Capital Holdings's STAAR Surgical position peaked at $233K in Q2 2022.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Freestone Capital Holdings's 13F filing for Q2 2023, filed 9 Aug 2023.